Literature DB >> 33875709

Ubiquitin specific peptidase Usp53 regulates osteoblast versus adipocyte lineage commitment.

Hadla Hariri1,2, William N Addison1, René St-Arnaud3,4,5,6.   

Abstract

We have previously shown that parathyroid hormone (PTH) induces the phosphorylation of the DNA-binding protein Nascent polypeptide associated complex And Coregulator alpha (NACA), leading to nuclear translocation of NACA and activation of target genes. Using ChIP-Seq against NACA in parallel with RNA-sequencing, we report the identification of Ubiquitin Specific Peptidase 53 (Usp53) as a target gene of PTH-activated NACA in osteoblasts. A binding site for NACA within the ChIP fragment from the Usp53 promoter was confirmed by electrophoretic mobility shift assay. Activity of the Usp53 promoter (- 2325/+ 238 bp) was regulated by the JUN-CREB complex and this activation relied on activated PKA and the presence of NACA. Usp53 knockdown in ST2 stromal cells stimulated expression of the osteoblastic markers Bglap2 (Osteocalcin) and Alpl (Alkaline phosphatase) and inhibited expression of the adipogenic markers Pparg and Cebpa. A similar effect was measured when knocking down Naca. During osteoblastogenesis, the impact of Usp53 knockdown on PTH responses varied depending on the maturation stage of the cells. In vivo implantation of Usp53-knockdown bone marrow stromal cells in immunocompromised mice showed an increase in osteoblast number and a decrease in adipocyte counts. Our data suggest that Usp53 modulates the fate of mesenchymal cells by impacting lineage selection.

Entities:  

Year:  2021        PMID: 33875709     DOI: 10.1038/s41598-021-87608-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  33 in total

1.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.

Authors:  R L Jilka; R S Weinstein; T Bellido; P Roberson; A M Parfitt; S C Manolagas
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases.

Authors:  Víctor Quesada; Araceli Díaz-Perales; Ana Gutiérrez-Fernández; Cecilia Garabaya; Santiago Cal; Carlos López-Otín
Journal:  Biochem Biophys Res Commun       Date:  2004-01-30       Impact factor: 3.575

Review 3.  Normal mineral homeostasis. Interplay of parathyroid hormone and vitamin D.

Authors:  Michael A Levine
Journal:  Endocr Dev       Date:  2003

Review 4.  A genomic and functional inventory of deubiquitinating enzymes.

Authors:  Sebastian M B Nijman; Mark P A Luna-Vargas; Arno Velds; Thijn R Brummelkamp; Annette M G Dirac; Titia K Sixma; René Bernards
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

Review 5.  Breaking the chains: structure and function of the deubiquitinases.

Authors:  David Komander; Michael J Clague; Sylvie Urbé
Journal:  Nat Rev Mol Cell Biol       Date:  2009-08       Impact factor: 94.444

Review 6.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

7.  Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts.

Authors:  Sang Wan Kim; Paola Divieti Pajevic; Martin Selig; Kevin J Barry; Jae-Yeon Yang; Chan Soo Shin; Wook-Young Baek; Jung-Eun Kim; Henry M Kronenberg
Journal:  J Bone Miner Res       Date:  2012-10       Impact factor: 6.741

8.  Defining the human deubiquitinating enzyme interaction landscape.

Authors:  Mathew E Sowa; Eric J Bennett; Steven P Gygi; J Wade Harper
Journal:  Cell       Date:  2009-07-16       Impact factor: 41.582

9.  Control of bone mass and remodeling by PTH receptor signaling in osteocytes.

Authors:  Charles A O'Brien; Lilian I Plotkin; Carlo Galli; Joseph J Goellner; Arancha R Gortazar; Matthew R Allen; Alexander G Robling; Mary Bouxsein; Ernestina Schipani; Charles H Turner; Robert L Jilka; Robert S Weinstein; Stavros C Manolagas; Teresita Bellido
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

10.  Progressive Hearing Loss in Mice Carrying a Mutation in Usp53.

Authors:  Marcin Kazmierczak; Suzan L Harris; Piotr Kazmierczak; Prahar Shah; Valentin Starovoytov; Kevin K Ohlemiller; Martin Schwander
Journal:  J Neurosci       Date:  2015-11-25       Impact factor: 6.167

View more
  1 in total

1.  USP25 Expression in Peripheral Blood Mononuclear Cells Is Associated With Bone Mineral Density in Women.

Authors:  Jianlin Shen; Bowen Fu; Yanjiao Wu; Yang Yang; Xiaoning Lin; Haibin Lin; Huan Liu; Wenhua Huang
Journal:  Front Cell Dev Biol       Date:  2022-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.